GLAUKOS ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM

Intraocular Pressure Lowering Implant

FDA Premarket Approval P080030 S012

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the modifications to the model gts100i inserter and stent, which comprise the istent trabecular micro-bypass stent system. The modifications include thefollowing:1) changes to the inserter to include:a) a larger sleeve diameter for increased rigidity of the slide assembly;b) an increase in the internal spring force; c) a change to the geometry and extension of the grasping tines on the end of the slotted tube; d) a re-design of the release button rocker mechanism; and e) color changes to two outer inserter components (rear housing and trigger button). 2) changes to the stent to include:a) an increase in the wall thickness of the snorkel by tightening the dimensional tolerance from a range 0. 155 to 0. 200 mm to a range of 0. 170 to 0. 200 mm; and b) removal of the stenting height parameter from the finished device drawings 10-0018 and 10-0019 as a critical dimension. 3) changes to the stent system to include:a) a change from sterilization following primary packaging to sterilization following final packaging; and b) elimination of the in-process grip force testing step.

DeviceGLAUKOS ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM
Classification NameIntraocular Pressure Lowering Implant
Generic NameIntraocular Pressure Lowering Implant
ApplicantGLAUKOS, CORPORATION
Date Received2014-09-30
Decision Date2014-12-16
PMAP080030
SupplementS012
Product CodeOGO
Advisory CommitteeOphthalmic
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address GLAUKOS, CORPORATION 26051 Merit Circle, Suite 103 laguna Hills, CA 92653

Supplemental Filings

Supplement NumberDateSupplement Type
P080030Original Filing
S024 2022-05-31 Normal 180 Day Track
S023 2022-02-04 30-day Notice
S022 2018-11-21 30-day Notice
S021 2018-03-01 Normal 180 Day Track
S020 2017-02-13 Normal 180 Day Track
S019 2016-11-07 30-day Notice
S018 2015-12-15 Normal 180 Day Track No User Fee
S017 2015-05-26 Normal 180 Day Track No User Fee
S016 2015-05-22 Normal 180 Day Track No User Fee
S015
S014 2015-02-11 Real-time Process
S013 2015-02-09 Normal 180 Day Track No User Fee
S012 2014-09-30 Normal 180 Day Track
S011 2014-08-01 30-day Notice
S010 2013-07-30 30-day Notice
S009 2013-05-23 30-day Notice
S008 2013-04-05 30-day Notice
S007 2013-02-19 30-day Notice
S006 2012-08-21 30-day Notice
S005 2012-07-20 Normal 180 Day Track No User Fee
S004 2012-07-20 Normal 180 Day Track No User Fee
S003 2012-07-20 Normal 180 Day Track No User Fee
S002 2012-07-09 135 Review Track For 30-day Notice
S001 2012-06-29 135 Review Track For 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.